THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT05194423

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05194423
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05194423. Allocation not applicable; no masking; primary purpose treatment. Start 2022-03-01 (anticipated); primary completion 2027-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein
Condition
Tricuspid Valve Regurgitation
Intervention (Device)
Tricuspid Valve Replacement System via jugular vein
Lead sponsor
Changhai Hospital (class: other)
Collaborator
Shanghai Zhongshan Hospital (class: other)
Collaborator
Fu Wai Hospital, Beijing, China (class: other)
Collaborator
Beijing Anzhen Hospital (class: other)
Collaborator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (class: other)
Collaborator
West China Hospital (class: other)
Collaborator
Xijing Hospital (class: other)
Collaborator
Guangdong Provincial People's Hospital (class: other)
Collaborator
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct05194423
Content hash
09c7a65f929976c905c4155bb1bf5fe5dfc5eb533e1023aeed24437ea5e16b65